Please use this identifier to cite or link to this item:
https://hdl.handle.net/1959.11/27771
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Garratt, Deborah | en |
dc.contributor.author | Turner, Joseph V | en |
dc.date.accessioned | 2019-11-14T00:58:48Z | - |
dc.date.available | 2019-11-14T00:58:48Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | The European Journal of Contraception and Reproductive Health Care, 23(3), p. 242-243 | en |
dc.identifier.issn | 1473-0782 | en |
dc.identifier.issn | 1362-5187 | en |
dc.identifier.uri | https://hdl.handle.net/1959.11/27771 | - |
dc.description.abstract | Dear Sir, A response to the recent case-report ‘Progesterone for preventing pregnancy termination after initiation of medical abortion with mifepristone’ opens with the question ‘what’s the real point here?’ in the title. Perhaps the simple answer is in the title of this reply as well as in the concluding paragraph of the original case report. It is worthwhile, however, further addressing the noteworthy issues raised by the respondent. | en |
dc.language | en | en |
dc.publisher | Taylor & Francis | en |
dc.relation.ispartof | The European Journal of Contraception and Reproductive Health Care | en |
dc.title | Providing women with full reproductive choice options: the point of researching medical abortion reversal | en |
dc.type | Journal Article | en |
dc.identifier.doi | 10.1080/13625187.2018.1459545 | en |
dc.identifier.pmid | 29671354 | en |
local.contributor.firstname | Deborah | en |
local.contributor.firstname | Joseph V | en |
local.subject.for2008 | 111404 Reproduction | en |
local.subject.for2008 | 111502 Clinical Pharmacology and Therapeutics | en |
local.subject.seo2008 | 920114 Reproductive System and Disorders | en |
local.subject.seo2008 | 920206 Health Inequalities | en |
local.profile.school | School of Rural Medicine | en |
local.profile.email | Joseph.Turner@une.edu.au | en |
local.output.category | C4 | en |
local.record.place | au | en |
local.record.institution | University of New England | en |
local.publisher.place | United Kingdom | en |
local.format.startpage | 242 | en |
local.format.endpage | 243 | en |
local.identifier.scopusid | 85045771586 | en |
local.identifier.volume | 23 | en |
local.identifier.issue | 3 | en |
local.title.subtitle | the point of researching medical abortion reversal | en |
local.contributor.lastname | Garratt | en |
local.contributor.lastname | Turner | en |
dc.identifier.staff | une-id:jturne59 | en |
local.profile.orcid | 0000-0002-0023-4275 | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.identifier.unepublicationid | une:1959.11/27771 | en |
local.date.onlineversion | 2018-04-19 | - |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
local.title.maintitle | Providing women with full reproductive choice options | en |
local.output.categorydescription | C4 Letter of Note | en |
local.search.author | Garratt, Deborah | en |
local.search.author | Turner, Joseph V | en |
local.istranslated | No | en |
local.uneassociation | Yes | en |
local.atsiresearch | No | en |
local.sensitive.cultural | No | en |
local.identifier.wosid | 000434668100011 | en |
local.year.available | 2018 | en |
local.year.published | 2018 | en |
local.fileurl.closedpublished | https://rune.une.edu.au/web/retrieve/8ff15582-0098-43dc-8049-6ab8181e06c7 | en |
local.subject.for2020 | 321503 Reproduction | en |
local.subject.for2020 | 321402 Clinical pharmacology and therapeutics | en |
local.subject.seo2020 | 200204 Health inequalities | en |
Appears in Collections: | Journal Article School of Rural Medicine |
Files in This Item:
File | Size | Format |
---|
SCOPUSTM
Citations
1
checked on Nov 23, 2024
Page view(s)
2,038
checked on Aug 3, 2024
Download(s)
4
checked on Aug 3, 2024
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.